Survival in adult inpatients with COVID-19
Sign Up to like & getrecommendations! Published in 2020 at "Public Health"
DOI: 10.1016/j.puhe.2020.10.029
Abstract: Background The mortality of the COVID-19 pandemic is high and data regarding its prognosis is scarce. We aimed to assess the survival experience and determining factors in adult inpatients with laboratory-confirmed COVID-19. Methods We conducted… read more here.
Keywords: survival adult; inpatients covid; adult inpatients;
Association of Frailty with Mortality in Older Inpatients with Covid-19: A Cohort Study
Sign Up to like & getrecommendations! Published in 2020 at "Age and Ageing"
DOI: 10.1093/ageing/afaa184
Abstract: Abstract Background COVID-19 has disproportionately affected older people. Objective to investigate whether frailty is associated with all-cause mortality in older hospital inpatients, with COVID-19. Design cohort study. Setting secondary care acute hospital. Participants six hundred… read more here.
Keywords: association frailty; mortality older; mortality; inpatients covid ... See more keywords
The Influence of Infection and Colonization on Outcomes in Inpatients With COVID-19: Are We Forgetting Something?
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Public Health"
DOI: 10.3389/fpubh.2021.747791
Abstract: The COVID-19 epidemic has been a great challenge to health systems and especially hospitals. A prospective observational epidemiological study was planned as of February 26, 2020 in a tertiary hospital in the Valencia region. The… read more here.
Keywords: colonization; colonization outcomes; infection colonization; inpatients covid ... See more keywords
Heparin and SARS-CoV-2: Multiple Pathophysiological Links
Sign Up to like & getrecommendations! Published in 2021 at "Viruses"
DOI: 10.3390/v13122486
Abstract: Low molecular weight heparin, enoxaparin, has been one of most used drugs to fight the SARS-CoV-2 pandemic. Pharmacological properties of heparin recognize its specific ability, as with other oligosaccharides and glycosaminoglycan, to bind several types… read more here.
Keywords: multiple pathophysiological; sars cov; pathophysiological links; cov multiple ... See more keywords
In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 d
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Internal Medicine"
DOI: 10.7326/j21-0019
Abstract: SOURCE CITATION Spyropoulos AC, Goldin M, Giannis D, et al. Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial.… read more here.
Keywords: inpatients covid; risk inpatients; high risk; dose ... See more keywords
In inpatients with COVID-19 who need supplemental oxygen, lenzilumab increased ventilation-free survival
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Internal Medicine"
DOI: 10.7326/j22-0019
Abstract: SOURCE CITATION Temesgen Z, Burger CD, Baker J, et al. Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial. Lancet Respir Med. 2022;10:237-46. 34863332. read more here.
Keywords: supplemental oxygen; inpatients covid; oxygen lenzilumab; covid need ... See more keywords